General Medicine and Primary Care

General Medicine and Primary Care

By ReachMDMedicine
Download on the App Store

General Medicine and Primary Care episodes

  • Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    6 min
  • The Dose Matters: Optimizing Statin Intensity in ASCVD Management
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    3 min
  • Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
    Host: Riccardo Maria Inciardi, MD, PhD

    Listen to Dr. Riccardo Inciardi’s summary from the ESC Preventive Cardiology 2025 meeting, where he highlights new therapies reshaping the management of cardio-kidney-metabolic (CKM) syndrome and heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Watch as he breaks down the latest clinical trial data showing that SGLT2 inhibitors, GLP-1 receptor agonists, and the nonsteroidal MRA finerenone can meaningfully reduce hospitalizations, kidney disease progression, and cardiovascular mortality. A real-life patient case illustrates how combining these therapies—under the care of a multidisciplinary team—can transform outcomes.

    14 min
  • Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    8 min
  • Target in Sight: Escalating Therapy to Reach LDL-C Goals
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    6 min
  • Bridging ASCVD Care Between Academic and Rural Settings
    Host: Rishi Wadhera, MD, MPP, Mphil
    Guest: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    5 min
  • Statins and Safety: What the Data Say About Dementia, Cancer, and More
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    8 min
  • When and Why to Use CAC Scoring
    Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
    Guest: Rishi Wadhera, MD, MPP, Mphil

    Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.

    5 min
  • Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
    Guest: prof. Hiddo Heerspink
    Guest: Jennifer B. Green, MD

    Can combining a nonsteroidal MRA and an SGLT2 inhibitor unlock new clinical potential for patients with type 2 diabetes and chronic kidney disease (CKD)? In this expert discussion, Dr. Jennifer Green and Dr. Hiddo Heerspink review the latest findings from the CONFIDENCE trial, which demonstrated a significant additive reduction in albuminuria—an important surrogate marker for kidney and cardiovascular risk—when finerenone and empagliflozin are used together. They explore the clinical rationale behind combination therapy, address persistent challenges in CKD detection, and consider the practical implications for implementing these therapies in high-risk populations.

    16 min
  • What's New in Dermatology: Key Updates on Emerging Therapies
    Guest: James Del Rosso, DO, FAOCD
    Host: Charles Turck, PharmD, BCPS, BCCCP

    Explore the latest breakthroughs in dermatology care with Dr. James Del Rosso, who highlights newly approved and emerging therapies for severe alopecia area, actinic keratosis, and atopic dermatitis. Dr. Del Rosso is the Research Director at JDR Dermatology Research, an Adjunct Clinical Professor of Dermatology at Touro University Nevada, and a practicing dermatologist in Las Vegas. He also presented on this topic at the 2025 Fall Clinical Dermatology Conference for Physician Assistants and Nurse Practitioners.

    14 min